EXHIBIT 8.2 [Letterhead of Latham & Watkins] October 29, 2002 Cohesion Technologies, Inc. 2500 Faber Place Palo Alto, California 94303 Re: Agreement and Plan of Reorganization, dated as of September 27, 2002, among Angiotech Pharmaceuticals, Inc.,...Agreement and Plan of Reorganization • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledOctober 30th, 2002 Company Industry
BACKGROUNDExecutive Employment Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
BACKGROUNDExecutive Employment Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
LEASE FALSE CREEK RESEARCH PARK 1618 STATION STREET VANCOUVER, B.C.Lease Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
EXHIBIT 4.1 SHAREHOLDER RIGHTS PLAN AGREEMENT DATED AS OF FEBRUARY 10, 1999 AND AS AMENDED MARCH 5, 2002Shareholder Rights Plan Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
EXHIBIT 10.15 EXECUTIVE CHANGE OF CONTROL AGREEMENT This Agreement is made as of August 23, between Angiotech Pharmaceuticals (U.S.), Inc., a Washington corporation having an office at Suite 6501, 701 5th Avenue, Seattle, Washington, 98104 ("Angiotech...Executive Change of Control Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
EXHIBIT 2.1 AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
EXHIBIT 10.11 EXECUTIVE CHANGE OF CONTROL AGREEMENT This Agreement is made as of June 6, 2000, between Angiotech Pharmaceuticals. Inc., a British Columbia corporation having an office at 6660 N.W. Marine Drive, Vancouver, British Columbia V6T 1Z4 (the...Executive Change of Control Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledOctober 30th, 2002 Company Industry
EXHIBIT 10.6 Employment Agreement This Agreement is made as of the 31st day of October, 1994, between ANGIOGENESIS TECHNOLOGIES INC., a British Columbia company (the "Company") and DR. WILLIAM HUNTER (the "Employee"). WHEREAS the Company and its...Employment Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction
EXHIBIT 10.7 EMPLOYMENT AGREEMENT This Agreement is made as of the 31st day of October, 1994, between ANGIOGENESIS TECHNOLOGIES INC., a British Columbia company (the "Company") and DAVID M. HALL (the "Employee"). WHEREAS the Company and its affiliate...Employment Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 30th, 2002 Company Industry Jurisdiction